Compounds > 2,4-diaminopyrimidine
Page last updated: 2024-08-24

2,4-diaminopyrimidine and Small Cell Lung Carcinoma

2,4-diaminopyrimidine has been researched along with Small Cell Lung Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, Y; Chen, L; Ding, J; Fang, B; Feng, C; Feng, J; Fu, W; Hu, J; Liang, G; Liu, Z; Qiu, Y; Qu, R; Tong, L; Xie, H; Zheng, L1

Other Studies

1 other study(ies) available for 2,4-diaminopyrimidine and Small Cell Lung Carcinoma

ArticleYear
Structure-based design and synthesis of 2,4-diaminopyrimidines as EGFR L858R/T790M selective inhibitors for NSCLC.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Animals; Cell Line, Tumor; ErbB Receptors; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Molecular Structure; Pyrimidines; Small Cell Lung Carcinoma; Structure-Activity Relationship

2017